Directions: Chew 1 tablet after a meal or more as directed by a physician. IMPORTANT: Briefly chew each tablet separately, swallow with a sip of water.
Ingredients: 1 Tablet supplies:
Total Carbohydrates <1 g
Total Sugars <1 g
Calcium (as calcium carbonate) 27 mg
Magnesium (as magnesium carbonate) 12 mg
Potassium (as potassium bicarbonate) 23 mg
Pectin 100 mg
Lecithin (soy) 50 mg
Mucin 50 mg
Other Ingredients: Microcrystalline Cellulose, Fructose, Citric Acid, Natural Vanilla Flavoring, Silicon Dioxide, Magnesium Stearate, Dextrose.
The information provided is for educational purposes only and is not intended to replace professional medical advice. Always consult with a qualified healthcare provider for personalized medical guidance.
The information provided is for educational purposes only and is not intended to replace professional medical advice. Always consult with a qualified healthcare provider for personalized medical guidance.
Refluxin is formulated to help alleviate the symptoms of heartburn, a common issue associated with GERD (Gastroesophageal Reflux Disease). It works by reducing the production of stomach acid, which can help in providing relief from heartburn.
Refluxin can help in reducing the occurrence of acid reflux episodes, which can cause discomfort and pain in individuals suffering from GERD. By controlling stomach acid levels, Refluxin can minimize the chances of acid reflux.
Continuous exposure to stomach acid due to GERD can lead to damage to the esophagus. Refluxin can help in protecting the esophagus by lowering the acid levels in the stomach, thus reducing the risk of complications such as esophagitis.
By managing the symptoms of GERD effectively, Refluxin can contribute to an improved quality of life for individuals suffering from this condition. Relief from heartburn and acid reflux can lead to better sleep, reduced discomfort, and overall well-being.
The information provided is for educational purposes only and is not intended to replace professional medical advice. Always consult with a qualified healthcare provider for personalized medical guidance.
Sources: Refluxin Official Website
The information provided is for educational purposes only and is not intended to replace professional medical advice. Always consult with a qualified healthcare provider for personalized medical guidance.
Refluxin is a medication commonly used to treat Gastroesophageal Reflux Disease (GERD). Let's compare Refluxin with some similar products:
Nexium is another proton pump inhibitor (PPI) like Refluxin, used to reduce stomach acid and treat GERD. Both medications work by reducing the production of stomach acid. However, studies have shown that Nexium may provide more effective acid suppression compared to Refluxin in some individuals.
Zantac is an H2 blocker that works by reducing the amount of acid produced in the stomach. While both Refluxin and Zantac are effective in treating GERD, Zantac may take longer to provide relief compared to Refluxin. However, Zantac has been associated with some safety concerns, leading to its discontinuation in some countries.
Prilosec is another PPI used to treat GERD by reducing stomach acid production. Both Refluxin and Prilosec are effective in managing GERD symptoms. Some studies suggest that Prilosec may have a slightly faster onset of action compared to Refluxin.
It is important to consult with a healthcare provider to determine the most suitable medication for your individual condition and needs.
The information provided is for educational purposes only and is not intended to replace professional medical advice. Always consult with a qualified healthcare provider for personalized medical guidance.
While Refluxin is a common medication used to treat GERD (Gastroesophageal Reflux Disease), there are other alternatives available that can be considered. One such alternative is:
Nexium is a medication in the same class as Refluxin (proton pump inhibitors) and is commonly used to treat GERD. It works by reducing the amount of acid produced in the stomach, helping to relieve symptoms of acid reflux.
According to the maker of Nexium, AstraZeneca, the medication is FDA-approved for the treatment of GERD and has been shown to be effective in reducing symptoms such as heartburn, regurgitation, and difficulty swallowing.
It is important to consult with a healthcare provider before starting any new medication, including Nexium, to determine the most appropriate treatment for your individual condition.
The information provided is for educational purposes only and is not intended to replace professional medical advice. Always consult with a qualified healthcare provider for personalized medical guidance.
©1996-2026 BetterLife.com, Inc. All rights reserved, Designated trademarks and brands are the property of their respective owners. The products and the claims made about specific products on or through this site have not been evaluated by betterLife.com Inc. or the United States Food and Drug Administration and are not approved to diagnose, treat, cure or prevent disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should NOT use the information on this site for diagnosis or treatment of any health problems or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.
The Terms "Suggested Retail Price" or "Retail Price" denote the Manufacturer's Suggested Retail Price. The product may be sold by vendors at a different price. The Terms "Savings" or "Your Savings" refer to the difference between the "Suggested Retail Price" and the price being offered by betterlife.com Inc. The Term "Below Retail" refers to the difference between the "Suggested Retail Price" and the price being offered by betterlife.com Inc.